1. Home
  2. HGLB vs RCEL Comparison

HGLB vs RCEL Comparison

Compare HGLB & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HGLB
  • RCEL
  • Stock Information
  • Founded
  • HGLB 1998
  • RCEL N/A
  • Country
  • HGLB United States
  • RCEL United States
  • Employees
  • HGLB N/A
  • RCEL N/A
  • Industry
  • HGLB Trusts Except Educational Religious and Charitable
  • RCEL Medical/Dental Instruments
  • Sector
  • HGLB Finance
  • RCEL Health Care
  • Exchange
  • HGLB Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • HGLB 195.7M
  • RCEL 170.8M
  • IPO Year
  • HGLB N/A
  • RCEL N/A
  • Fundamental
  • Price
  • HGLB $8.62
  • RCEL $5.96
  • Analyst Decision
  • HGLB
  • RCEL Strong Buy
  • Analyst Count
  • HGLB 0
  • RCEL 4
  • Target Price
  • HGLB N/A
  • RCEL $17.25
  • AVG Volume (30 Days)
  • HGLB 91.8K
  • RCEL 347.9K
  • Earning Date
  • HGLB 01-01-0001
  • RCEL 05-08-2025
  • Dividend Yield
  • HGLB 13.16%
  • RCEL N/A
  • EPS Growth
  • HGLB N/A
  • RCEL N/A
  • EPS
  • HGLB N/A
  • RCEL N/A
  • Revenue
  • HGLB N/A
  • RCEL $71,661,000.00
  • Revenue This Year
  • HGLB N/A
  • RCEL $59.50
  • Revenue Next Year
  • HGLB N/A
  • RCEL $28.89
  • P/E Ratio
  • HGLB N/A
  • RCEL N/A
  • Revenue Growth
  • HGLB N/A
  • RCEL 41.35
  • 52 Week Low
  • HGLB $6.42
  • RCEL $5.46
  • 52 Week High
  • HGLB $9.45
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • HGLB 65.86
  • RCEL 25.13
  • Support Level
  • HGLB $8.13
  • RCEL $5.46
  • Resistance Level
  • HGLB $8.65
  • RCEL $6.38
  • Average True Range (ATR)
  • HGLB 0.17
  • RCEL 0.43
  • MACD
  • HGLB 0.01
  • RCEL -0.10
  • Stochastic Oscillator
  • HGLB 93.15
  • RCEL 5.33

About HGLB Highland Global Allocation Fund

Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: